265 related articles for article (PubMed ID: 31046707)
1. Anti-Ebola therapy for patients with Ebola virus disease: a systematic review.
Lee JS; Adhikari NKJ; Kwon HY; Teo K; Siemieniuk R; Lamontagne F; Chan A; Mishra S; Murthy S; Kiiza P; Hajek J; Bah EI; Lamah MC; Kao R; Fowler RA
BMC Infect Dis; 2019 May; 19(1):376. PubMed ID: 31046707
[TBL] [Abstract][Full Text] [Related]
2. Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea.
Sissoko D; Laouenan C; Folkesson E; M'Lebing AB; Beavogui AH; Baize S; Camara AM; Maes P; Shepherd S; Danel C; Carazo S; Conde MN; Gala JL; Colin G; Savini H; Bore JA; Le Marcis F; Koundouno FR; Petitjean F; Lamah MC; Diederich S; Tounkara A; Poelart G; Berbain E; Dindart JM; Duraffour S; Lefevre A; Leno T; Peyrouset O; Irenge L; Bangoura N; Palich R; Hinzmann J; Kraus A; Barry TS; Berette S; Bongono A; Camara MS; Chanfreau Munoz V; Doumbouya L; Souley Harouna ; Kighoma PM; Koundouno FR; Réné Lolamou ; Loua CM; Massala V; Moumouni K; Provost C; Samake N; Sekou C; Soumah A; Arnould I; Komano MS; Gustin L; Berutto C; Camara D; Camara FS; Colpaert J; Delamou L; Jansson L; Kourouma E; Loua M; Malme K; Manfrin E; Maomou A; Milinouno A; Ombelet S; Sidiboun AY; Verreckt I; Yombouno P; Bocquin A; Carbonnelle C; Carmoi T; Frange P; Mely S; Nguyen VK; Pannetier D; Taburet AM; Treluyer JM; Kolie J; Moh R; Gonzalez MC; Kuisma E; Liedigk B; Ngabo D; Rudolf M; Thom R; Kerber R; Gabriel M; Di Caro A; Wölfel R; Badir J; Bentahir M; Deccache Y; Dumont C; Durant JF; El Bakkouri K; Gasasira Uwamahoro M; Smits B; Toufik N; Van Cauwenberghe S; Ezzedine K; D'Ortenzio E; Pizarro L; Etienne A; Guedj J; Fizet A; Barte de Sainte Fare E; Murgue B; Tran-Minh T; Rapp C; Piguet P; Poncin M; Draguez B; Allaford Duverger T; Barbe S; Baret G; Defourny I; Carroll M; Raoul H; Augier A; Eholie SP; Yazdanpanah Y; Levy-Marchal C; Antierrens A; Van Herp M; Günther S; de Lamballerie X; Keïta S; Mentre F; Anglaret X; Malvy D;
PLoS Med; 2016 Mar; 13(3):e1001967. PubMed ID: 26930627
[TBL] [Abstract][Full Text] [Related]
3. A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection.
; ; Davey RT; Dodd L; Proschan MA; Neaton J; Neuhaus Nordwall J; Koopmeiners JS; Beigel J; Tierney J; Lane HC; Fauci AS; Massaquoi MBF; Sahr F; Malvy D
N Engl J Med; 2016 Oct; 375(15):1448-1456. PubMed ID: 27732819
[TBL] [Abstract][Full Text] [Related]
4. Clinical and Virological Characteristics of Ebola Virus Disease Patients Treated With Favipiravir (T-705)-Sierra Leone, 2014.
Bai CQ; Mu JS; Kargbo D; Song YB; Niu WK; Nie WM; Kanu A; Liu WW; Wang YP; Dafae F; Yan T; Hu Y; Deng YQ; Lu HJ; Yang F; Zhang XG; Sun Y; Cao YX; Su HX; Sun Y; Liu WS; Wang CY; Qian J; Liu L; Wang H; Tong YG; Liu ZY; Chen YS; Wang HQ; Kargbo B; Gao GF; Jiang JF
Clin Infect Dis; 2016 Nov; 63(10):1288-1294. PubMed ID: 27553371
[TBL] [Abstract][Full Text] [Related]
5. Review: Insights on Current FDA-Approved Monoclonal Antibodies Against Ebola Virus Infection.
Tshiani Mbaya O; Mukumbayi P; Mulangu S
Front Immunol; 2021; 12():721328. PubMed ID: 34526994
[TBL] [Abstract][Full Text] [Related]
6. Current status of chemically synthesized inhibitors of Ebola virus.
Cardile AP; Mayers DL; Bavari S
Recent Pat Antiinfect Drug Discov; 2014; 9(2):97-103. PubMed ID: 25808170
[TBL] [Abstract][Full Text] [Related]
7. Will There Be a Cure for Ebola?
Cardile AP; Warren TK; Martins KA; Reisler RB; Bavari S
Annu Rev Pharmacol Toxicol; 2017 Jan; 57():329-348. PubMed ID: 27959624
[TBL] [Abstract][Full Text] [Related]
8. Treatment of ebola virus disease.
Kilgore PE; Grabenstein JD; Salim AM; Rybak M
Pharmacotherapy; 2015 Jan; 35(1):43-53. PubMed ID: 25630412
[TBL] [Abstract][Full Text] [Related]
9. Effect of Artesunate-Amodiaquine on Mortality Related to Ebola Virus Disease.
Gignoux E; Azman AS; de Smet M; Azuma P; Massaquoi M; Job D; Tiffany A; Petrucci R; Sterk E; Potet J; Suzuki M; Kurth A; Cannas A; Bocquin A; Strecker T; Logue C; Pottage T; Yue C; Cabrol JC; Serafini M; Ciglenecki I
N Engl J Med; 2016 Jan; 374(1):23-32. PubMed ID: 26735991
[TBL] [Abstract][Full Text] [Related]
10. Nubia's mother: being pregnant in the time of experimental vaccines and therapeutics for Ebola.
Caluwaerts S
Reprod Health; 2017 Dec; 14(Suppl 3):157. PubMed ID: 29297408
[TBL] [Abstract][Full Text] [Related]
11. Effects of therapies for Ebola virus disease: a systematic review and network meta-analysis.
Gao Y; Zhao Y; Guyatt G; Fowler R; Kojan R; Ge L; Tian J; ; Hao Q
Lancet Microbe; 2022 Sep; 3(9):e683-e692. PubMed ID: 35803293
[TBL] [Abstract][Full Text] [Related]
12. In Vivo Activity of Amodiaquine against Ebola Virus Infection.
DeWald LE; Johnson JC; Gerhardt DM; Torzewski LM; Postnikova E; Honko AN; Janosko K; Huzella L; Dowling WE; Eakin AE; Osborn BL; Gahagen J; Tang L; Green CE; Mirsalis JC; Holbrook MR; Jahrling PB; Dyall J; Hensley LE
Sci Rep; 2019 Dec; 9(1):20199. PubMed ID: 31882748
[TBL] [Abstract][Full Text] [Related]
13. Laboratory Findings, Compassionate Use of Favipiravir, and Outcome in Patients With Ebola Virus Disease, Guinea, 2015-A Retrospective Observational Study.
Kerber R; Lorenz E; Duraffour S; Sissoko D; Rudolf M; Jaeger A; Cisse SD; Camara AM; Miranda O; Castro CM; Akoi Bore J; Raymond Koundouno F; Repits J; Afrough B; Becker-Ziaja B; Hinzmann J; Mertens M; Vitoriano I; Hugh Logue C; Böttcher JP; Pallasch E; Sachse A; Bah A; Cabeza-Cabrerizo M; Nitzsche K; Kuisma E; Michel J; Holm T; Zekeng EG; Cowley LA; Garcia-Dorival I; Hetzelt N; Baum JHJ; Portmann J; Carter L; Yenamaberhan RL; Camino A; Enkirch T; Singethan K; Meisel S; Mazzarelli A; Kosgei A; Kafetzopoulou L; Rickett NY; Patrono LV; Ghebreghiorghis L; Arnold U; Colin G; Juchet S; Marchal CL; Kolie JS; Beavogui AH; Wurr S; Bockholt S; Krumkamp R; May J; Stoecker K; Fleischmann E; Ippolito G; Carroll MW; Koivogui L; Magassouba N; Keita S; Gurry C; Drury P; Diallo B; Formenty P; Wölfel R; Di Caro A; Gabriel M; Anglaret X; Malvy D; Günther S
J Infect Dis; 2019 Jun; 220(2):195-202. PubMed ID: 30788508
[TBL] [Abstract][Full Text] [Related]
14. A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics.
Mulangu S; Dodd LE; Davey RT; Tshiani Mbaya O; Proschan M; Mukadi D; Lusakibanza Manzo M; Nzolo D; Tshomba Oloma A; Ibanda A; Ali R; Coulibaly S; Levine AC; Grais R; Diaz J; Lane HC; Muyembe-Tamfum JJ; ; Sivahera B; Camara M; Kojan R; Walker R; Dighero-Kemp B; Cao H; Mukumbayi P; Mbala-Kingebeni P; Ahuka S; Albert S; Bonnett T; Crozier I; Duvenhage M; Proffitt C; Teitelbaum M; Moench T; Aboulhab J; Barrett K; Cahill K; Cone K; Eckes R; Hensley L; Herpin B; Higgs E; Ledgerwood J; Pierson J; Smolskis M; Sow Y; Tierney J; Sivapalasingam S; Holman W; Gettinger N; Vallée D; Nordwall J;
N Engl J Med; 2019 Dec; 381(24):2293-2303. PubMed ID: 31774950
[TBL] [Abstract][Full Text] [Related]
15. Preliminary Evaluation of the Effect of Investigational Ebola Virus Disease Treatments on Viral Genome Sequences.
Whitmer SL; Albariño C; Shepard SS; Dudas G; Sheth M; Brown SC; Cannon D; Erickson BR; Gibbons A; Schuh A; Sealy T; Ervin E; Frace M; Uyeki TM; Nichol ST; Ströher U
J Infect Dis; 2016 Oct; 214(suppl 3):S333-S341. PubMed ID: 27521366
[TBL] [Abstract][Full Text] [Related]
16. Recent progress on the treatment of Ebola virus disease with Favipiravir and other related strategies.
Zhang T; Zhai M; Ji J; Zhang J; Tian Y; Liu X
Bioorg Med Chem Lett; 2017 Jun; 27(11):2364-2368. PubMed ID: 28462833
[TBL] [Abstract][Full Text] [Related]
17. Favipiravir: a new medication for the Ebola virus disease pandemic.
Nagata T; Lefor AK; Hasegawa M; Ishii M
Disaster Med Public Health Prep; 2015 Feb; 9(1):79-81. PubMed ID: 25544306
[TBL] [Abstract][Full Text] [Related]
18. Antiviral efficacy of favipiravir against Ebola virus: A translational study in cynomolgus macaques.
Guedj J; Piorkowski G; Jacquot F; Madelain V; Nguyen THT; Rodallec A; Gunther S; Carbonnelle C; Mentré F; Raoul H; de Lamballerie X
PLoS Med; 2018 Mar; 15(3):e1002535. PubMed ID: 29584730
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model.
Oestereich L; Lüdtke A; Wurr S; Rieger T; Muñoz-Fontela C; Günther S
Antiviral Res; 2014 May; 105():17-21. PubMed ID: 24583123
[TBL] [Abstract][Full Text] [Related]
20. A systematic review of Ebola virus disease outbreaks and an analysis of the efficacy and safety of newer drugs approved for the treatment of Ebola virus disease by the US Food and Drug Administration from 2016 to 2020.
Sivanandy P; Jun PH; Man LW; Wei NS; Mun NFK; Yii CAJ; Ying CCX
J Infect Public Health; 2022 Mar; 15(3):285-292. PubMed ID: 35085865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
